|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/68 | (2006.01) |
| G01N 33/86 | (2013.01) | ||
| G01N 33/86 | (2006.01) | ||
| G01N 33/6893 | (2013.01) | ||
| A61P 7/10 | (2018.01) |
| (11) | Number of the document | 3839514 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20209278.9 |
| Date of filing the European patent application | 2016-10-19 | |
| (97) | Date of publication of the European application | 2021-06-23 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-13 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201562243505 P | 2015-10-19 | US | |
| 201662335311 P | 2016-05-12 | US |
| (72) |
SEXTON, Daniel J. , US
FAUCETTE, Ryan , US
COSIC, Janja , US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | IMMUNOASSAY TO DETECT CLEAVED HIGH MOLECULAR WEIGHT KININOGEN |
| IMMUNOASSAY TO DETECT CLEAVED HIGH MOLECULAR WEIGHT KININOGEN |